TP53TG1 and Bloom syndrome: To assess the potential therapeutic benefit of TP53TG1 on BLM models that were already established, we intratracheal injected AAV5-TP53TG1 five days after BLM induction and euthanized the mice 21 days after BLM injection (Fig. 6a).